+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use



Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use



Journal of Thrombosis and Thrombolysis 7(2): 157-163




(PDF emailed within 0-6 h: $19.90)

Accession: 046567523

Download citation: RISBibTeXText

PMID: 10364772

DOI: 10.1023/a:1008884004751


Related references

Frailty Status Affects the Decision for Long-Term Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation. Drugs & Aging 35(10): 897-905, 2018

Current status of anticoagulation therapy for elderly atrial fibrillation patients in Japan: from Hokuriku atrial fibrillation trial. Circulation Journal 72(12): 2058-2061, 2008

Current status of the long-term adherence to warfarin anticoagulation therapy in patients with non-valvular atrial fibrillation. Zhonghua Xin Xue Guan Bing Za Zhi 45(11): 920-923, 2017

Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents. Clinical Research in Cardiology 102(11): 799-806, 2014

Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Cerebrovascular Diseases 29(1): 73-78, 2010

Outcomes of long-term anticoagulation in frail elderly patients with atrial fibrillation. Clinical Drug Investigation 17(6): 483-488, June, 1999

Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation. Chest 113(4): 1115-1118, 1998

Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation 125(13): 1605-1616, 2012

Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study. Journal of the American College of Cardiology 59(9): 854-855, 2012

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis. Circulation 129(9): 961-970, 2014

Letter by Bonaque et al regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy". Circulation 127(2): E277-E277, 2013

Chronic atrial fibrillation Success rate of serial cardioversion therapy and long-term safety and efficacy of oral anticoagulation. European Heart Journal 17(ABSTR SUPPL ): 201, 1996

Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation. Vascular Pharmacology 83: 26-35, 2017

Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study). American Heart Journal 183: 108-114, 2017

Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation. International Heart Journal 51(2): 98-104, 2010